BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 4152327)

  • 1. The natural (and unnatural) history of hypertrophic obstructive cardiomyopathy.
    Shah PM; Adelman AG; Wigle ED; Gobel FL; Burchell HB; Hardarson T; Curiel R; De La Calzada C; Oakley CM; Goodwin JF
    Circ Res; 1974 Aug; 35(2):suppl II:179-95. PubMed ID: 4152327
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical and echocardiographic observations in patients after surgical treatment of hypertrophic obstructive cardiomyopathy (author's transl)].
    Köhler E; Neuhaus C; Thurow J; Bluschke V; Kuhn H; Krelhaus W; Körfer R; Loogen F; Bircks W
    Z Kardiol; 1978 Dec; 67(12):826-36. PubMed ID: 735290
    [No Abstract]   [Full Text] [Related]  

  • 3. Medical and surgical treatment of the cardiomyopathies.
    Wigle ED; Adelman AG; Felderhof CH
    Circ Res; 1974 Aug; 35(2):suppl II:196-207. PubMed ID: 4858427
    [No Abstract]   [Full Text] [Related]  

  • 4. [Cardiomyopathies (VII). Natural history of hypertrophic cardiomyopathy].
    Sáenz de la Calzada C; Tello de Meneses R; Delgado Jiménez J; Gómez Pajuelo C; Gómez Sánchez MA; González Cocina E
    Rev Esp Cardiol; 1996 Mar; 49(3):214-25. PubMed ID: 8685525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Course observations of hypertrophic obstructive myocardiopathy].
    Loogen F; Krelhaus W; Kuhn H
    Z Kardiol; 1976 Jun; 65(6):511-21. PubMed ID: 936724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Analysis of sudden death due to idiopathic cardiomyopathies].
    Kanoh T; Kudo K; Fukuda K; Abe H; Okada R
    Nihon Rinsho; 1980; 38(5):2169-80. PubMed ID: 6447817
    [No Abstract]   [Full Text] [Related]  

  • 7. [Natural history of hypertrophic obstructive cardiomyopathy in young patients: apropos of 40 cases].
    Azzano O; Bozio A; Sassolas F; Di Filippo S; Agé C; André M; Jocteur-Monrozier D; Normand J
    Arch Mal Coeur Vaiss; 1995 May; 88(5):667-72. PubMed ID: 7646275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognosis and mortality of hypertrophic obstructive cardiomyopathy.
    Hardarson T; De la Calzada CS; Curiel R; Goodwin JF
    Lancet; 1973 Dec; 2(7844):1462-7. PubMed ID: 4129311
    [No Abstract]   [Full Text] [Related]  

  • 9. [Primary familial cardiomyopathy].
    Rau Z; Kuroszczyk-Rusiecka B; Krzemińska-Pakula M; Musial J; Kulig A
    Kardiol Pol; 1976; 19(5):417-21. PubMed ID: 994370
    [No Abstract]   [Full Text] [Related]  

  • 10. Predictors of death from congestive heart failure in hypertrophic cardiomyopathy.
    Ikeda H; Maki S; Yoshida N; Murohara T; Adachi H; Koga Y; Imaizumi T
    Am J Cardiol; 1999 Apr; 83(8):1280-3, A9. PubMed ID: 10215301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardioselective beta blockade in hypertrophic cardiomyopathy.
    Webb-Peplos MM; Croxson RS; Khanna P; Raphael MJ; Steiner RE; Oakley CM; Goodwin JF
    Acta Cardiol; 1972; ():Suppl 15:263-7. PubMed ID: 4147610
    [No Abstract]   [Full Text] [Related]  

  • 12. Double-blind trial of propranolol and practolol in hypertrophic cardiomyopathy.
    Hubner PJ; Ziady GM; Lane GK; Hardarson T; Scales B; Oakley CM; Goodwin JF
    Br Heart J; 1973 Nov; 35(11):1116-23. PubMed ID: 4586631
    [No Abstract]   [Full Text] [Related]  

  • 13. Quebec beer-drinkers' cardiomyopathy: clinical signs and symptoms.
    Mercier G; Patry G
    Can Med Assoc J; 1967 Oct; 97(15):884-8. PubMed ID: 6051257
    [No Abstract]   [Full Text] [Related]  

  • 14. [Difficulties in diagnosis in primary cardiomyopathies in infants (author's transl)].
    Moniuk O; Roszkowska W; Zawistowska E; Chyczewska A
    Probl Med Wieku Rozwoj; 1975; 5():285-9. PubMed ID: 1223884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary cardiomyopathies: classification, pathophysiology, clinical recognition and management.
    Seward JB; Tajik AJ
    Cardiovasc Clin; 1980; 10(3):199-230. PubMed ID: 6445779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Ventricular hypertrophy and risk of sudden death in hypertrophic cardiomyopathy].
    Cecchi F
    Ital Heart J Suppl; 2000 Dec; 1(12):1648-9. PubMed ID: 11221596
    [No Abstract]   [Full Text] [Related]  

  • 17. Prognosis of patients with hypertrophic obstructive cardiomyopathy after transaortic myectomy. Late results up to twenty-five years.
    Schulte HD; Bircks WH; Loesse B; Godehardt EA; Schwartzkopff B
    J Thorac Cardiovasc Surg; 1993 Oct; 106(4):709-17. PubMed ID: 8412267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Presumed primary non-obstructive myocardiopathies in children and adolescents].
    Gérard R; Gatau-Pelanchon J; Heuillet G; Amichot JL; Jouve A
    Arch Mal Coeur Vaiss; 1972 Jan; 65(1):51-63. PubMed ID: 4625260
    [No Abstract]   [Full Text] [Related]  

  • 19. Significance and relation between magnitude of left ventricular hypertrophy and heart failure symptoms in hypertrophic cardiomyopathy.
    Maron MS; Zenovich AG; Casey SA; Link MS; Udelson JE; Aeppli DM; Maron BJ
    Am J Cardiol; 2005 Jun; 95(11):1329-33. PubMed ID: 15904638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Natural history on hypertrophic obstructive cardiomyopathy: observations on 107 patients.
    Loogen F; Krelhaus W; Kübler W
    Recent Adv Stud Cardiac Struct Metab; 1973; 2():629-37. PubMed ID: 4283355
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.